Physician

Emily Zaruhi Touloukian, D.O.

According to 2025 Medicare claims, Emily Touloukian, D.O. (NPI: 1053577718) practices hematology/oncology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is COASTAL CANCER CENTER LLC (NPI: 1881614170; TIN: 570777346) and primary practice location at 29572-4128.

Touloukian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 873 traditional Medicare patients, billed 134,699 HCPCS/CPT codes, and received $2,095,435 in Medicare payments. The top billing code was 36415 (Insertion of needle into vein for collection of blood sample). Part D data shows 900 prescription claims across 234 beneficiaries totaling $4,178,694 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 43 claims. Open Payments data shows 19 records totaling $1,240. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $313,029 to $4,178,694. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $10,757 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,336	445,984	$2,890,689
2016	1,316	460,155	$3,451,708
2017	1,301	398,538	$3,090,961
2018	1,173	327,578	$2,690,265
2019	1,165	310,584	$2,808,544
2020	1,132	307,008	$3,719,149
2021	1,192	310,687	$3,510,307
2022	1,027	248,496	$3,717,068
2023	1,287	219,136	$3,485,644
2024	873	134,699	$2,095,435

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	184	784	$313,029
2016	187	747	$605,451
2017	187	728	$426,788
2018	210	777	$1,075,112
2019	194	707	$2,124,507
2020	227	822	$2,966,877
2021	237	760	$2,960,335
2022	235	826	$3,724,508
2023	235	832	$3,574,166
2024	234	900	$4,178,694

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	46	346	$74,201
2016	N/R	129	$35,069
2017	39	58	$6,782
2018	41	58	$6,181
2019	20	87	$11,629
2020	14	86	$7,091
2021	12	116	$10,398
2022	N/R	65	$3,136
2023	N/R	65	$19,066
2024	28	43	$7,274

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
36415	Insertion of needle into vein for collection of blood sample	730	2,343	$9
80076	Liver function blood test panel	680	1,703	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	729	2,246	$8
82565	Blood creatinine level	680	1,705	$5
84520	Urea nitrogen level to assess kidney function, quantitative	680	1,701	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	50	1,365	$735,661
Pomalyst	Pomalidomide	34	938	$722,590
Revlimid	Lenalidomide	30	812	$629,891
Calquence	Acalabrutinib Maleate	41	1,230	$595,977
Verzenio	Abemaciclib	20	560	$302,990

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8030	Breast prosthesis, silicone or equal, without integral adhesive	N	12	12	$4,161
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	16	31	$3,112

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$1,240	PROCEPT BioRobotics Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Emily Zaruhi Touloukian, D.O.?

Tedicare shows public-source Medicare data for Emily Zaruhi Touloukian, D.O. (NPI 1053577718), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Emily Zaruhi Touloukian, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Emily Zaruhi Touloukian, D.O.?

Emily Zaruhi Touloukian, D.O. is linked to COASTAL CANCER CENTER LLC (billing NPI 1881614170) in the available physician profile data.

Does Emily Zaruhi Touloukian, D.O. have Open Payments data?

Emily Zaruhi Touloukian, D.O. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.